Biomea Fusion logo

Biomea Fusion

We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.

99 employees · est. 2017 · United States

VS
Matchpoint Therapeutics logo

Matchpoint Therapeutics

Acing the future of covalent medicines

32 employees · est. 2021

Biomea Fusion is the older company (2017 vs 2021); Biomea Fusion is the larger of the two.

Side-by-Side Comparison

Biomea Fusion Matchpoint Therapeutics
Founded
2017 older 2021
Headquarters
United States Not tracked yet
Employees
99 larger 32
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Equity Series A
Total Funding
$206.00M $100.00M
Funding Rounds
2 2
Services
Not tracked yet Discovery of precision small molecule medicines, Chemoproteomics screening, Development of covalent drug libraries, Machine learning-driven drug design
Target Customers
Not tracked yet Pharmaceutical companies, Biotech investors, Healthcare providers, Research institutions in immunology
Taxonomy
Precision Medicine, Biopharmaceutical, Covalent Small Molecules, Genetically Defined Diseases, Cancer Treatment, Metabolic Diseases, FUSION™ System Platform, MENIN Inhibitor, Oncogenic Drivers, Drug Development, Covalent Bonding Chemistry, Clinical Benefit, Biomea Fusion, Biomedical Innovations, Life Sciences Covalent Medicines, Immunology, Precision Medicine, Chemoproteomics, Machine Learning In Biotech, Covalency, Drug Discovery, Pharmaceutical Research, Immune Diseases, Chemical Library Evolution, ACE Platform, Biotech Innovation
Website
biomeafusion.com matchpointtx.com
Biomea Fusion logo

About Biomea Fusion

Biomea Fusion is a biopharmaceutical company dedicated to revolutionizing precision medicine for genetically defined cancers and metabolic diseases. The company's proprietary FUSION™ System platform, leveraging covalent binding chemistry, aims to advance a pipeline of novel covalent therapies. Their...

Matchpoint Therapeutics logo

About Matchpoint Therapeutics

Matchpoint Therapeutics, founded in 2021, is at the forefront of innovation in the Biotechnology and Pharmaceutical industries. With the slogan "Acing the future of covalent medicines," the company is committed to revolutionizing the treatment landscape for immune diseases and other serious conditio...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Biomea Fusion and Matchpoint Therapeutics — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Biomea Fusion and Matchpoint Therapeutic... — by email.

Frequently Asked Questions

Biomea Fusion — We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.. Matchpoint Therapeutics — Acing the future of covalent medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biomea Fusion has raised $206.00M while Matchpoint Therapeutics has raised $100.00M.
Biomea Fusion and Matchpoint Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biomea Fusion with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy